Dhruvika Mukhija
Overview
Explore the profile of Dhruvika Mukhija including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurizzian P, Hackenberger J, Shaker V, Mukhija D, Bocian M, Smith T, et al.
Can Med Educ J
. 2025 Jan;
15(6):19-24.
PMID: 39807141
Background: The COVID-19 pandemic disrupted the healthcare system, affecting physician wellbeing. The consequences of reduced time spent with patients at bedside during the pandemic has not been investigated. The objectives...
2.
Shah A, Santa-Maria C, Mukhija D, Shah N, Kang A, Kumthekar P, et al.
Clin Breast Cancer
. 2023 Jan;
23(3):324-329.
PMID: 36621430
Introduction: Palbociclib is highly efficacious and well tolerated in hormone-receptor positive (HR+) metastatic breast cancer (BC) but its activity for HER2+ BC with brain metastases (BM) is unknown. Methods: In...
3.
Ayers E, Li S, Medeiros L, Bond D, Maddocks K, Torka P, et al.
Cancer
. 2019 Oct;
126(2):293-303.
PMID: 31568564
Background: Salvage immunochemotherapy followed by high-dose chemotherapy and autologous stem cell transplantation is the standard-of-care second-line treatment for patients with relapsed/refractory diffuse large B-cell lymphoma after first-line R-CHOP (rituximab, cyclophosphamide,...
4.
Brown T, Mukhija D, Premnath N, Venkatraman A, Nagpal S, Gupta A
Nutr Cancer
. 2019 May;
71(8):1272-1275.
PMID: 31045449
The neutropenic diet is commonly prescribed to cancer patients with neutropenia with the goal of reducing infections. However, multiple randomized trials have proved no benefit with neutropenic diets compared to...
5.
Mukhija D, Nagpal S, Sohal D
Am J Clin Oncol
. 2019 Apr;
42(5):454-458.
PMID: 30950860
Introduction: Primary pancreatic lymphoma (PPL) is an extranodal manifestation of non-Hodgkin lymphoma originating in the pancreas, which constitutes <1% of all pancreatic neoplasms. Because of the rarity of the disease,...
6.
Hill B, Nastoupil L, Winter A, Becnel M, Cerhan J, Habermann T, et al.
Br J Haematol
. 2018 Dec;
184(4):524-535.
PMID: 30575016
Bendamustine (B) with rituximab (R) is a standard frontline treatment for medically fit follicular lymphoma (FL) patients. The safety and efficacy of maintenance rituximab (MR) after BR induction has not...
7.
Ali S, Mukhija D, Nagpal S
Natl Med J India
. 2018 Aug;
30(6):362.
PMID: 30117456
No abstract available.
8.
Mukhija D, Sohal D, Khorana A
Pancreas
. 2018 Aug;
47(8):e50-e52.
PMID: 30113430
No abstract available.
9.
Tariq R, Mukhija D, Gupta A, Singh S, Pardi D, Khanna S
Infect Drug Resist
. 2018 Mar;
11:405-416.
PMID: 29559802
Purpose: Statins have pleiotropic effects beyond cholesterol lowering by immune modulation. The association of statins with primary infection (CDI) is unclear as studies have reported conflicting findings. We performed a...
10.
Mukhija D, Venkatraman A, Nagpal S
JMIR Public Health Surveill
. 2017 Aug;
3(3):e55.
PMID: 28827213
No abstract available.